- Home
- UTZ vs TVTX Comparison
UTZ vs TVTX Comparison
Compare UTZ & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTZ
- TVTX
- Stock Information
- Founded
- UTZ 2018
- TVTX 2008
- Country
- UTZ United States
- TVTX United States
- Employees
- UTZ N/A
- TVTX N/A
- Industry
- UTZ Packaged Foods
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- UTZ Consumer Staples
- TVTX Health Care
- Exchange
- UTZ Nasdaq
- TVTX Nasdaq
- Market Cap
- UTZ 1.4B
- TVTX 1.3B
- IPO Year
- UTZ N/A
- TVTX N/A
- Fundamental
- Price
- UTZ $16.30
- TVTX $17.72
- Analyst Decision
- UTZ Buy
- TVTX Buy
- Analyst Count
- UTZ 10
- TVTX 13
- Target Price
- UTZ $20.70
- TVTX $23.46
- AVG Volume (30 Days)
- UTZ 767.4K
- TVTX 1.4M
- Earning Date
- UTZ 10-31-2024
- TVTX 10-31-2024
- Dividend Yield
- UTZ 0.71%
- TVTX N/A
- EPS Growth
- UTZ N/A
- TVTX N/A
- EPS
- UTZ N/A
- TVTX N/A
- Revenue
- UTZ $1,420,335,000.00
- TVTX $203,447,000.00
- Revenue This Year
- UTZ N/A
- TVTX $62.45
- Revenue Next Year
- UTZ $3.13
- TVTX $59.30
- P/E Ratio
- UTZ N/A
- TVTX N/A
- Revenue Growth
- UTZ N/A
- TVTX 57.08
- 52 Week Low
- UTZ $12.82
- TVTX $5.12
- 52 Week High
- UTZ $20.04
- TVTX $20.33
- Technical
- Relative Strength Index (RSI)
- UTZ 41.53
- TVTX 51.53
- Support Level
- UTZ $16.73
- TVTX $16.89
- Resistance Level
- UTZ $17.82
- TVTX $19.51
- Average True Range (ATR)
- UTZ 0.65
- TVTX 1.23
- MACD
- UTZ -0.05
- TVTX -0.16
- Stochastic Oscillator
- UTZ 11.56
- TVTX 26.69
About UTZ Utz Brands Inc
Utz Brands Inc is a snack food manufacturing company. It manufactures a diverse portfolio of salty snacks under popular brands including Utz, Zapp's, Golden Flake, Boulder Canyon, Hawaiian, TORTIYAHS!, among others. The company's products include potato chips, tortilla chips, pretzels, cheese snacks, pork skins, veggie snacks, pub/party mixes, and other snacks.. Its products are distributed nationally and internationally through grocery, mass merchant, club, convenience, drug, and other channels. It operates in the given segment: the manufacturing, distribution, marketing and sale of snack food products.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.